CYCLERION THERAPEUTICS, INC. (KRSA) Total liabilities 2019–2025
CYCLERION THERAPEUTICS, INC. (KRSA) total liabilities at each fiscal year-end, per SEC filings.
$900,000FY2025 · since FY2019: $88.7M → $900,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $900,000 | +24.1% |
| FY2024 | $725,000 | -65.2% |
| FY2023 | $2.1M | -72.6% |
| FY2022 | $7.6M | -31.2% |
| FY2021 | $11.1M | -80.2% |
| FY2020 | $55.9M | -37.0% |
| FY2019 | $88.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Net marginKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating marginKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Shareholders’ equityKRSA overview →